Artificial intelligence can create art, write papers, even help predict illness.

What does it mean for the world of tech and you?

Check out Artificial E-Minded, a new weekly series from the Wall Street Journal's Tech

News Briefing, new episodes every Monday, all this month.

From the opinion pages of the Wall Street Journal, this is Potomac Watch.

The abortion drug, Mythopristone, is staying on the market after the fifth circuit court

of appeals stayed in injunction issued by a federal judge on the drug.

But the case seems destined to reach the Supreme Court.

Plus Florida Governor Ron DeSantis, as it he'll sign a pending Florida law that would ban

abortions after six weeks, a so-called heartbeat bill.

How will that play politically if the Florida Governor decides to run for?

President, the law and the politics of abortion policy is our topic for today on Potomac Watch.

And welcome.

I'm Paul Gigo, the editorial page editor.

I'm here with the colleague, Sa'Khalen-Levy, and Kim Straussle.

Let's take up the fifth circuit ruling first came in a little before midnight on late Wednesday.

And a two-to-one ruling overturned the national injunction over the Mythopristone by saying

that the plaintiffs who are pro-life doctors and judge Jean-Mathieu Kismarik, who had issued

the ruling and the injunction, had violated the statute of limitations of six years for

challenging an FDA decision to approve the drug, or the original decision of approval was

in the year 2000.

The appeals court did not let stand the judges' injunction on FDA rules that had loosened

...